T. Rowe Price Associates’s Agilon Health AGL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6,678	Closed	-$114K	–	3133
2025 Q4	$114K	Sell	6,678 -1,664	-20%	-$32.3K	﹤0.01%	2927
2025 Q3	$215K	Sell	8,342 -5,371	-39%	-$203K	﹤0.01%	2765
2025 Q2	$790K	Sell	13,713 -283	-2%	-$22.7K	﹤0.01%	2088
2025 Q1	$1.52M	Buy	13,996 +455	+3%	+$39.6K	﹤0.01%	1741
2024 Q4	$644K	Buy	13,541 +3,935	+41%	+$238K	﹤0.01%	2172
2024 Q3	$945K	Sell	9,606 -32,023	-77%	-$4.13M	﹤0.01%	1994
2024 Q2	$6.81M	Sell	41,629 -25,001	-38%	-$3.56M	﹤0.01%	1169
2024 Q1	$10.2M	Sell	66,630 -338,965	-84%	-$56.4M	﹤0.01%	1104
2023 Q4	$127M	Buy	405,595 +127,803	+46%	+$46.3M	0.02%	500
2023 Q3	$123M	Buy	277,792 +122,124	+78%	+$55.2M	0.02%	475
2023 Q2	$67.5M	Buy	155,668 +63,508	+69%	+$35.7M	0.01%	621
2023 Q1	$54.7M	Buy	92,160 +63,617	+223%	+$35.6M	0.01%	662
2022 Q4	$11.5M	Sell	28,543 -6,373	-18%	-$2.99M	﹤0.01%	1028
2022 Q3	$20.4M	Sell	34,916 -94,009	-73%	-$56.3M	﹤0.01%	895
2022 Q2	$70.4M	Sell	128,925 -7,508	-6%	-$3.8M	0.01%	770
2022 Q1	$86.5M	Sell	136,433 -27,956	-17%	-$14.4M	0.01%	779
2021 Q4	$111M	Sell	164,389 -20,616	-11%	-$12.5M	0.01%	730
2021 Q3	$121M	Buy	185,005 +9,821	+6%	+$8.39M	0.01%	701
2021 Q2	$178M	Buy	+175,184	New	+$153M	0.02%	597